Patricia D. Pelton
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Cholesterol and Lipid Metabolism, Phytase and its Applications, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism
Most-Cited Works
- → PPARγ Activation Induces the Expression of the Adipocyte Fatty Acid Binding Protein Gene in Human Monocytes(1999)187 cited
- → Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells(1998)128 cited
- → Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform(2009)88 cited
- → Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin(2000)60 cited
- → A Novel Method for Analysis of Nuclear Receptor Function at Natural Promoters: Peroxisome Proliferator-Activated Receptor γ Agonist Actions on aP2 Gene Expression Detected Using Branched DNA Messenger RNA Quantitation(1999)57 cited
- → Synthesis and Identification of [1,2,4]Thiadiazole Derivatives as a New Series of Potent and Orally Active Dual Agonists of Peroxisome Proliferator-Activated Receptors α and δ(2007)45 cited
- → Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors(2010)39 cited
- → Design, Synthesis, and Biological Evaluation of (2R,αS)-3,4-Dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-α-(trifluoromethyl)-1(2H)-quinolineethanol as Potent and Orally Active Cholesteryl Ester Transfer Protein Inhibitor(2009)38 cited
- → Inhibition of myo-inositol monophosphatase isoforms by aromatic phosphonates(1998)38 cited
- GW-501516 GlaxoSmithKline/Ligand.(2006)